Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02506803
What this trial is testing

Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 10
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Not applicableLooking for participantsNCT06914349
What this trial is testing

Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure

Who this might be right for
Pancreatic Cancer ResectablePancreas Neoplasms
University of Thessaly 76
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Testing effectiveness (Phase 2)Study completedNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Not applicableWithdrawnNCT06054308
What this trial is testing

Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study

Who this might be right for
Pancreatic Cancer
Chinese University of Hong Kong
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Zhejiang University 30
Testing effectiveness (Phase 2)Ended earlyNCT02910882
What this trial is testing

PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Scripps Health 4
Large-scale testing (Phase 3)UnknownNCT05181605
What this trial is testing

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Resectable
Instituto de investigación e innovación biomédica de Cádiz 116
Testing effectiveness (Phase 2)Study completedNCT01978184
What this trial is testing

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Who this might be right for
Pancreatic Cancer
Nathan Bahary, MD 104
Large-scale testing (Phase 3)Looking for participantsNCT07081360
What this trial is testing

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Who this might be right for
Pancreas CancerPeriampullary CancerPeriampullary Carcinoma Resectable+3 more
Minia University 262
Not applicableActive Not RecruitingNCT04423731
What this trial is testing

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaChemotherapy EffectBorderline Resectable Pancreatic Adenocarcinoma+1 more
Oslo University Hospital 251
Not applicableActive Not RecruitingNCT03704662
What this trial is testing

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Medical College of Wisconsin 102
Not applicableUnknownNCT05923567
What this trial is testing

New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase

Who this might be right for
Paancreatic Cancer
Gangnam Severance Hospital 150
Early research (Phase 1)Active Not RecruitingNCT04484909
What this trial is testing

NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+1 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT01774019
What this trial is testing

Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer

Who this might be right for
Pancreatic Carcinoma
Boston Scientific Corporation 284
Early research (Phase 1)Study completedNCT02930902
What this trial is testing

Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Resectable Pancreatic CarcinomaStage I Pancreatic Cancer AJCC v6 and v7Stage IA Pancreatic Cancer AJCC v6 and v7+4 more
M.D. Anderson Cancer Center 9
Not applicableNot Yet RecruitingNCT07713823
What this trial is testing

Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases

Who this might be right for
Pancreatic CancerPancreatic Cancer MetastaticPancreatic Cancer Non-resectable+1 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 3,000
Early research (Phase 1)Ended earlyNCT02782182
What this trial is testing

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Chicago 1
Next Page